| Literature DB >> 24557909 |
Neena K Pyzocha1, F Ann Ran, Patrick D Hsu, Feng Zhang.
Abstract
The microbial CRISPR-Cas adaptive immune system can be harnessed to facilitate genome editing in eukaryotic cells (Cong L et al., Science 339, 819-823, 2013; Mali P et al., Science 339, 823-826, 2013). Here we describe a protocol for the use of the RNA-guided Cas9 nuclease from the Streptococcus pyogenes type II CRISPR system to achieve specific, scalable, and cost-efficient genome editing in mammalian cells.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24557909 DOI: 10.1007/978-1-62703-761-7_17
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745